Cara Therapeutics (CARA)
(Delayed Data from NSDQ)
$0.68 USD
-0.02 (-2.24%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.68 0.00 (-0.63%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.38 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | -3.51% |
ABR | 1.50 |
Earnings ESP
|
0.87% |
---|---|
Current Year | -1.03 |
Next Year | -0.95 |
EPS (TTM) | -2.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.25M | 1.74M | 7.28M | 8.08M |
# of Estimates | 3 | 3 | 3 | 2 |
High Estimate | 3.02M | 3.54M | 13.66M | 12.55M |
Low Estimate | 1.23M | 0.08M | 1.98M | 3.60M |
Year ago Sales | 6.17M | 6.93M | 20.97M | 7.28M |
Year over Year Growth Est. | -63.53% | -74.89% | -65.28% | 10.92% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.38 | -0.24 | -1.03 | -0.95 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.38 | -0.25 | -0.84 | -0.68 |
High Estimate | -0.35 | -0.23 | -0.84 | -0.68 |
Low Estimate | -0.42 | -0.25 | -1.15 | -1.12 |
Year ago EPS | -0.49 | -0.58 | -2.19 | -1.03 |
Year over Year Growth Est. | 22.45% | 58.62% | 52.97% | 8.09% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.38 | -0.24 | -1.03 | -0.95 |
7 Days Ago | -0.38 | -0.24 | -1.03 | -0.95 |
30 Days Ago | -0.40 | -0.32 | -1.25 | -1.08 |
60 Days Ago | -0.40 | -0.32 | -1.25 | -0.94 |
90 Days Ago | -0.40 | -0.32 | -1.02 | -0.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.38 | -0.25 | -0.84 | -0.68 |
Zacks Consensus Estimate | -0.38 | -0.24 | -1.03 | -0.95 |
Earnings ESP | 0.87% | -4.17% | 18.45% | 28.17% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.52 | -0.58 | -0.49 | NA |
Estimate | -0.57 | -0.53 | -0.56 | -0.53 | NA |
Difference | -0.02 | 0.01 | -0.02 | 0.04 | 0.00 |
Surprise | -3.51% | 1.89% | -3.57% | 7.55% | 0.59% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more